Cardiology

Your Article Summary

See Latest Articles

Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence
Journal of Nephrology, 10/05/09

Kanbay M et al. – It seems that statins have renoprotective effects in the early CKD stages, and encouragingly, safety and tolerability of statins are no more a problem than in non–CKD patient cohorts. Statins seem to possess nephroprotective and cardioprotective properties which should be of great benefit to patients at risk of, or with, CKD.

Today in Chronic Dz/Renal Failure...keeping you current

Receive free subspecialty "5-minute updates" via email

Nephrogenic systemic fibrosis
Current Opinion in Rheumatology, 11/04/09

Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery
Critical Care, 11/06/09

Impact of Chronic Aspirin and Statin Therapy on Presentation of Patients With Acute Myocardial Infarction and Impaired Renal Function
Preventive Cardiology, 11/12/09

See All of Chronic Dz/Renal Failure

Today in Clinical Pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09

New Anticoagulants in Atrial Fibrillation
Seminars in Thrombosis and Hemostasis, 10/02/09

Antithrombotic medication for stroke prevention
Expert Review of Cardiovascular Therapy , 10/20/09

See All of Clinical Pharmacology

Today in Nephrology...keeping you current

Receive free subspecialty "5-minute updates" via email

Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy
Current Medical Research and Opinion, 11/20/09

Systematic Review: Sodium Bicarbonate Treatment Regimens for the Prevention of Contrast-Induced Nephropathy
Annals of Internal Medicine, 11/03/09

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, 10/27/09

See All of Nephrology

Today in Nephrology...keeping you current

Receive free subspecialty "5-minute updates" via email

Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy
Current Medical Research and Opinion, 11/20/09

Systematic Review: Sodium Bicarbonate Treatment Regimens for the Prevention of Contrast-Induced Nephropathy
Annals of Internal Medicine, 11/03/09

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, 10/27/09

See All of Nephrology

Today in Pharmacology/kinetics...keeping you current

Receive free subspecialty "5-minute updates" via email

Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Kidney International, 11/05/09

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09

Upfront, randomized, phase II trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma
Cancer, 11/03/09

See All of Pharmacology/kinetics

Today in Transplantation...keeping you current

Receive free subspecialty "5-minute updates" via email

Incidence and predictors of osteonecrosis among cyclosporin- or tacrolimus-treated renal allograft recipients
Rheumatology International, 11/04/09

Tubular Toxicity in Sirolimus- and Cyclosporine-Based Transplant Immunosuppression Strategies: An Ancillary Study From a Randomized Controlled Trial
American Journal of Kidney Diseases, 11/19/09

Hyperuricemia Is a Mediator of Endothelial Dysfunction and Inflammation in Renal Allograft Recipients
Transplantation Proceedings, 10/30/09

See All of Transplantation